← Back to Clinical Trials
Recruiting NCT06495359

NCT06495359 Effect of Immunization Education Program on Parental Vaccine Hesitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06495359
Status Recruiting
Phase
Sponsor Bilecik Seyh Edebali Universitesi
Condition Nurse's Role
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-03-01
Primary Completion 2024-07-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
immunization education program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-03-01 with a primary completion date of 2024-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Not administering vaccines due to vaccine hesitancy is both a potential public health problem and a difficult and risky situation for healthcare professionals. Health sector workers play a very important role in vaccinating families. As public awareness increases, interest in these vaccines is likely to increase. Made works; It shows that healthcare professionals and physicians establishing trust and communicating effectively with vaccine recipients and parents is one of the most effective ways to eliminate vaccine hesitations. They stated that in order for childhood vaccines to be administered at a high rate, effective communication should first be established with parents. This project aimed to determine the effect of the immunization education program on parents' vaccine hesitancy. The project is designed as a randomized controlled study and will consist of experimental and control groups. An education program regarding immunization will be applied to the parents in the experimental group. The originality of this project is the evaluation of the effect of the immunization education program applied to parents whose children are hospitalized on vaccine hesitancy. Although studies on vaccine hesitancy in parents have increased in recent years, most of them consist of descriptive studies aimed at determining the level of vaccine hesitancy and affecting factors. No intervention studies on the effect of immunization education in parents on vaccine hesitancy have been found.

Eligibility Criteria

Inclusion Criteria: * Having a child between the ages of 0-6, * admitted to the pediatric ward, * who have not previously received training on immunization * Parents who volunteered to participate in the study Exclusion Criteria: * illiterate * parents with mental retardation, vision and hearing impairment

Contact & Investigator

Central Contact

AKDENİZ KUDUBEŞ, PHD

✉ asli.akdeniz@bilecik.edu.tr

📞 5432715190

Principal Investigator

AKDENİZ KUDUBEŞ

STUDY DIRECTOR

BİLECİK ŞEYH EDEBALİ UNIVERSITY

Frequently Asked Questions

Who can join the NCT06495359 clinical trial?

This trial is open to participants of all sexes, studying Nurse's Role. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06495359 currently recruiting?

Yes, NCT06495359 is actively recruiting participants. Contact the research team at asli.akdeniz@bilecik.edu.tr for enrollment information.

Where is the NCT06495359 trial being conducted?

This trial is being conducted at Bilecik, Turkey (Türkiye).

Who is sponsoring the NCT06495359 clinical trial?

NCT06495359 is sponsored by Bilecik Seyh Edebali Universitesi. The principal investigator is AKDENİZ KUDUBEŞ at BİLECİK ŞEYH EDEBALİ UNIVERSITY. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology